Skip to main content
. Author manuscript; available in PMC: 2015 Dec 9.
Published in final edited form as: Pediatr Infect Dis J. 2014 Nov;33(11):1164–1168. doi: 10.1097/INF.0000000000000444

TABLE 2.

Varicella Vaccine Effectiveness Against All Varicella and Moderate/Severe Varicella in Public School Students of West Virginia, 2010–2011

Cases, n (%) Controls, n (%) VE (95% CI) P Value
All varicella cases and matched controls N = 133 N = 365
 Unvaccinated 57 (42.9) 36 (9.9) Reference
  1-dose 56 (42.1) 181 (49.6) 83.2 (69.2–90.8) <0.001
  2-dose 20 (15.0) 148 (40.6) 93.9 (86.9–97.1) <0.001
  Incremental (1-dose recipients as reference) 63.6 (32.6–80.3) 0.001
Moderate/severe cases and matched controls N = 77 N = 216
 Unvaccinated 43 (55.8) 24 (11.1) Reference
  1-dose 28 (36.4) 107 (49.5) 88.2 (72.7–94.9) <0.001
  2-dose 6 (7.8) 85 (39.4) 97.5 (91.6–99.2) <0.001
  Incremental (1-dose recipients as reference) 78.6 (40.9–92.3) 0.003

VE indicates vaccine effectiveness; 95% CI, 95% confidence interval.